Olix Pharmaceuticals Inc. logo

Olix Pharmaceuticals Inc. (226950)

Market Closed
10 Aug, 06:30
KRX SM KRX SM
137,800. 00
+16,600
+13.6964%
2.4T Market Cap
- P/E Ratio
- Div Yield
408,419 Volume
- Eps
121,200
Previous Close
Add Transaction
Day Range
124,100 139,700
Year Range
48,850 217,000
Want to track 226950 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Olix Pharmaceuticals Inc. (226950) Statistics

Valuation metrics

Market Cap 2.4T
Enterprise value 2.47T
Trailing P/E (ttm) -201.2
Forward P/E -
PEG ratio -1.48
Price/Sales (ttm) 142.53
Price/Book (mrq) 18.61
Enterprise Value/Revenue 143.15
Enterprise Value/EBITDA -130.43

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 285.21K
Average volume (90 days) 331.2K

Price summary

52-Week low 48,850
52-Week high 217,000
Beta -
50-Day moving average 125,425.71
200-Day moving average 151,564.44

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 3 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.71%
Operating margin -1.88%

Operational effectiveness

Return on assets -0.07%
Return on equity -0.11%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 777.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -551.42
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 5,757.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 6.59%
Book value per share (mrq) 6,545.83

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -